Detailed explanation of the latest price of cabozantinib in 2025: a must-read for patients

Cabozantinib (Cabozantinib) is a multi-target tyrosine kinase inhibitor mainly used to treat malignant tumors such as advanced renal cell carcinoma, hepatocellular carcinoma and medullary thyroid carcinoma. As a prescription drug, cabozantinib plays an important role in clinical treatment, especially for patients who are refractory to conventional treatments. However, the price of cabozantinib is a big challenge for many patients, especially when the selling price of the drug varies greatly between different countries and regions.

The price of cabozantinib varies by region, drug supplier, and purchase channel. Cabozantinib, as an important anti-cancer drug, has not yet been officially launched in mainland China, so its specific price is not yet clear. In the domestic market, the common cabozantinib tablet specifications include 20mg*30 tablets, 40mg*30 tablets and 60mg*30 tablets. Each box is expected to sell for about 50,000 yuan. However, in the international market, cabozantinib has been launched in Japan, Türkiye, Europe and other places, and is available in tablets and capsules. Taking tablets as an example, each box may be sold for about 30,000 yuan, while capsule preparations may be sold for 40,000 yuan (the specific price will vary due to exchange rates).

When purchasing cabozantinib, patients should first consider the legality and safety of the drug. Cabozantinib is a prescription drug that must be prescribed by a doctor before it can be legally purchased by patients. In addition, there are various types of generic cabozantinib drugs available in overseas markets. These generic drugs are similar in efficacy to the original drug. For example, countries such as Laos, Bangladesh, and India have all produced generic versions of cabozantinib. The package of 20mg*90 tablets launched by Laos United Pharmaceuticals may be sold for less than 100 yuan (also affected by the exchange rate).

Reference:https://en.wikipedia.org/wiki/Cabozantinib